# Transmucular Quadratus Lumborum Block: Potential Quadriceps Muscle Weakness

> **NCT05023343** · PHASE4 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Ropivacaine
- **OTHER:** Quadriceps muscle strength
- **OTHER:** Timed Up and Go
- **OTHER:** Single-leg 6 meter timed hop test
- **OTHER:** Temperature discrimination
- **OTHER:** Pinprick test
- **DIAGNOSTIC_TEST:** Blood samples
- **DIAGNOSTIC_TEST:** Non-invasive blood pressure measurement

## Key facts

- **NCT ID:** NCT05023343
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-02
- **Primary completion:** 2021-11-28
- **Final completion:** 2021-11-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05023343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05023343, "Transmucular Quadratus Lumborum Block: Potential Quadriceps Muscle Weakness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05023343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*